Balyasny Asset Management

Balyasny Asset Management’s Verona Pharma VRNA Stock Holding History

Balyasny Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$199M	Buy
2025 Q2	$56.1M	Buy
2025 Q1	$29.3M	Buy
2024 Q4	$8.54M	Buy
2023 Q4	–	Sell
2023 Q3	$163K	Buy